Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) administered by subcutaneous injection. Approved by the FDA for the reduction of visceral abdominal fat in HIV patients and lipodystrophy, it is also used off-label by athletes and bodybuilders for body composition optimization and recovery.

Main Benefits:

• Targeted reduction of abdominal visceral fat

• Preservation of lean muscle mass during fat loss

• Natural increase in growth hormone (GH) and IGF-1 levels

• Improved muscle recovery and recovery time between workouts

• Supports collagen synthesis and connective tissue repair.

• Beneficial metabolic effects without estrogen conversion

• Potential improvement in cognitive function and sleep quality

• Preserves the sensitivity of GH receptors (unlike synthetic GH)

Typical Dosages:

- Adults: 1.4-2 mg per day (subcutaneous injection)

Cycle duration: 12-16 weeks (minimum recommended)

- Administration: Preferably before bedtime to align with natural rhythms.

Protocol: 5 days a week with 2 days off (optional)

Tesamorelin is considered a safer option compared to synthetic growth hormone because it works with the body's natural hormonal rhythms. Effects manifest gradually, with visible results in 4-6 weeks and full benefits after 12 weeks of consistent use. Regular monitoring of IGF-1 and glucose levels is required during use. Not recommended for pregnant women, individuals with active tumors, or pituitary gland problems.